The Business of Oncology Summit is a conference organized and designed specifically for pharmaceutical representatives, physicians, advance practice providers, nurses, practice administrators, pharmacists, social workers, financial counselors and others that are concerned with the business side of the oncology field. This conference will provide an emphasis on the business of oncology that focuses on specific financial driven topics addressing the current and future challenges in the landscape of cancer care. The Spring Session is a clinical focused meeting. Both events will offer continuing education hours.
This year’s theme for the Business of Oncology Summit is, “Barriers to Access”. Examine how BARRIERS TO ACCESS is affecting the patients and their providers. Understand the BURDENS to INNOVATIVE CARE. During the Spring Session, attendees will hear a presentation on new treatments for Cancer and a panel discussion utilizing several case studies.
Featured Topics at the Business of Oncology event:
- The Vision for Cancer Care
- Paying for Care: Evolving Value-Based Payer Initiatives
- Legislative / Regulatory Insights
- Medicare Advantage and Patient Access to Care: a growing dilemma
- Social Determinants of Health and Implications for Cancer
- The Information Conundrum
Meeting Announcement
More info coming soon!
Spring Agenda
Continuing Education
Evaluation & Certificate of Attendance
In order to receive CME/CE/CPE credits for this program:
- You MUST sign in at the registration desk.
- Complete and submit the Evaluation Survey which will be emailed to you within (5) business days post-conference. Please complete this within the allotted time frame. Please add @meccinc.com to your contacts to ensure receipt of your evaluation email. For your convenience, you can complete the evaluation using your desktop or mobile device. Your certificate of attendance will be emailed to you for download immediately after submission. Please keep this document for your files.
Accreditation and Credit Statements
In support of improving patient care, this activity has been planned and implemented by the Medical Educator Consortium and the Florida Society of Medical Oncology. The Medical Educator Consortium is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.
This activity was planned by and for the healthcare team, and learners will receive .0 Interprofessional Continuing Education (IPCE) credit for learning and change.
Physician – The Medical Educator Consortium designates this live activity for a maximum of 0.0 AMA PRA Category 1 Credit(s)™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
Nursing – The Medical Educator Consortium designates this activity for 0.0 contact hours. Pharmacotherapy contact hours for Advance Practice Registered Nurses will be designated on your certificate.
Pharmacist – This Application based activity has been approved for 0.0 contact hours (.0 CEUs) by the Medical Educator Consortium. The Universal Activity Number for this program is JA4008179-9999-19-020-L01-P. Your CE credits will be electronically submitted to CPE Monitor® within 60 days upon successful completion of the activity.
Physician Assistant The Medical Educator Consortium has been authorized by the American Academy of PAs (AAPA) to award AAPA Category 1 CME credit for activities planned in accordance with AAPA CME Criteria. This activity is designated for 0.0 AAPA Category 1 CME credits. PAs should only claim credit commensurate with the extent of their participation.
Disclosure Policy – The Medical Educator Consortium (MEC) adheres to the Joint Accreditation Criteria and ACCME Standards for Commercial Support, which requires everyone in a position of controlling the content of a CME/CE activity to disclose all relevant financial relationships with commercial interests related to the activity content. MEC has implemented a mechanism to identify and resolve all conflicts of interest prior to the CME/CE activity being delivered to learners. The source of all support from commercial interests will also be disclosed to learners prior to the beginning of the educational activity. CME/CE activities must be balanced, independent of commercial bias, and designed to improve quality in health care. All recommendations involving clinical medicine must be based on evidence within the medical profession.
Disclosure of Unlabeled Use – This educational activity may contain discussion of published and/or investigational uses of agents that are not indicated by the FDA. The planners of this activity do not recommend the use of any agent outside of the labeled indications. The opinions expressed in the educational activity are those of the faculty and do not necessarily represent the views of the planners. Please refer to the official prescribing information for each product for discussion of approved indications, contradictions, and warnings.
Disclaimer – Participants have an implied responsibility to use the newly acquired information to enhance patient outcomes and their own professional development. The information presented in this activity is not meant to serve as a guideline for patient management. Any procedures, medications, or other courses of diagnosis or treatment discussed or suggested in this activity should not be used by clinicians without evaluation of their patient’s conditions and possible contradictions and/or dangers in use, review of any applicable manufacturer’s product information, and comparison with recommendations of other authorities.
Accredited by 
Poster Presentation
Invitation to Submit Abstracts for Presentation
The Florida Society of Clinical Oncology (FLASCO) invites FLASCO members to submit an abstract detailing your research endeavors for presentation at the FLASCO Spring Session to be held at the Gaylord Palms Resort & Convention Center on April 3 & 4.
Presenter and research will be vetted by the FLASCO Abstract Review Committee. Abstracts of superior quality will be selected by the FLASCO Ad Hoc Abstract Committee for presentation at the FLASCO Spring Meeting and for publication on the FLASCO website. The FLASCO Committee strongly encourages the submission of abstracts on research directly influencing the cancer health and outcomes of Floridians.
Abstracts are due by March 4, 2020 and will be judged solely on the data submitted. Notification regarding acceptance or rejection of abstracts will be sent by email to the Approved Presenter on or before March 11, 2020.
Exhibit Info
TO: All Corporate Members/Exhibitors (click here for printable PDF of invite)
FROM: Julie Newberry, FLASCO Executive Director
The 2019 FLASCO Spring Session meetings is being held on April 3 & 4 at the Gaylord Palms Convention Center, 6000 West Osceola Parkway, Kissimmee, FL 34746. Click the meeting announcement tab to see session agendas for the FLASCO Business of Oncology Summit and Spring Session.
EXHIBIT INFO: FLASCO would like to invite your company to exhibit at this meeting. We are expecting 100-125 attendees at the FLASCO Spring Session The cost is $2,000 for all companies with the exception of our Diamond Elite, Diamond, and Platinum, for which the fee is waived and the FLASCO Gold Corporate Members who are asked to pay an exhibit fee of $250 and the FLASCO Silver Corporate Members who are asked to pay an exhibit fee of $500. Please complete and submit the Exhibit Reply Form by March 4.
| Exhibit Set-up | Friday, April 3, 2020 | 3:00 pm – 5:00 pm | |
| Exhibit Hours | Friday, April 3, 2020 | 6:00 pm – 7:30 pm | (Cash Bar in exhibit room) |
| Saturday, April 4, 2020 | 7:00 am – 8:00 am | (Breakfast in exhibit room) | |
| 10:00 am – 10:45 am | (Break in exhibit room) | ||
| Exhibit Dismantle | 11:00 am – 12:00 pm |
REGISTRATION & MEALS FEES:
Diamond Elite Members: No Exhibit Fee for (3) 6’exhibit tables & (5) representatives
Diamond Members: No Exhibit Fee for (2) 6’exhibit table & (4) representatives
Platinum Members: No Exhibit Fee for (1) 6’ exhibit table & (3) representatives
Gold Members: $500 Exhibit Fee for (1) 6’ table & (2) representatives
Exhibitors: $2,000 Exhibit Fee for (1) 6’ table & (2) representatives
*Additional Representatives: $250 for each additional representative over the designated number above. FLASCO Corporate Members may reserve additional tables at the discounted rate of $1,000.
**If not exhibiting, registration fee per representative to attend the FLASCO Spring Session is $500/or waived with paid registration of attendance to the FLASCO Business of Oncology Summit.
***We ask that ALL representatives register to attend CLICK HERE.***
HOTEL RESERVATIONS: Attendees are asked to be responsible for making their own hotel reservations. Please call: (877) 382-7299 and refer to Florida Society of Clinical Oncology to reserve your room. Deadline: The hotel has requested that all room reservations be made prior to March 4, 2020. After that date reservations will only be accepted on a space and rate-available basis.
- Room Rates: Special sleeping room rates have been extended to FLASCO at the rate of $212 (plus applicable taxes and other hotel fees). Rate is available three (3) days prior to meeting and three (3) days following meeting.
- Parking: Gaylord Palms Convention Center offers self parking for overnight guests for $24 & valet parking charges for overnight guests for $35.
- Internet Charges: Gaylord Palms Convention Center offers complimentary wireless internet in all sleeping rooms and in public spaces. Internet will not be available within meeting rooms.
- Electric & Misc. Hotel Charges: All electrical and misc. needs will need to be paid for by the exhibitor through the Gaylord Palms Convention Center. Click here for information.
Hotel
HOTEL RESERVATIONS: Attendees are asked to be responsible for making their own hotel reservations with the Gaylord Palms Convention Center staff, 6000 West Osceola Parkway, Kissimmee, FL 34746. Please call: (877) 382-7299 and refer to Florida Society of Clinical Oncology to reserve your room. Deadline: The hotel has requested that all room reservations be made prior to March 4, 2020. After that date reservations will only be accepted on a space and rate-available basis.
- Room Rates: Special sleeping room rates have been extended to FLASCO at the rate of $212 (plus applicable taxes and other hotel fees). Rate is available three (3) days prior to meeting and three (3) days following meeting.
- Parking: Gaylord Palms Convention Center offers self parking for overnight guests for $24 & valet parking charges for overnight guests for $35.
- Internet Charges: Gaylord Palms Convention Center offers complimentary wireless internet in all sleeping rooms and in public spaces. Internet will not be available within meeting rooms.
PowerPoints
More info coming soon!
Gallery
More info coming soon!